Discover
RGNX
REGENXBIO Inc.
13.09
2 x 9.73
2 x 15.21
bid
ask
+
1.11
9.27%
2 @ 06:25 AM
13.32 +0.23 (1.74%)
| Ytd | -9.10% | |
| 1y | 51.86% |
11.89
day range
13.68
5.46
52 week range
16.19
| Open | 11.89 | Prev Close | 11.98 | Low | 11.89 | High | 13.68 | Mkt Cap | 676.72M |
| Vol | 4.44M | Avg Vol | 1.71M | EPS | -5.60 | P/E | N/A | Forward P/E | -6.83 |
| Beta | 1.23 | Short Ratio | 6.02 | Inst. Own | 92.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 8.21 | 200-d Avg | 10.39 | 1yr Est | 37.64 |
| Income Statement | |||
| Total Revenue | 6.39M | ||
| Revenues (USD) | 6.39M | ||
| Cost of Revenue | 11.07M | ||
| Gross Profit | -4.68M | ||
| Operating Expenses | 78.68M | ||
| Research and Development Expense | 57.34M | ||
| Selling, General and Administrative Expense | 21.31M | ||
| Operating Income | -83.36M | ||
| Interest Expense | 8.71M | ||
| Net Income | -90.05M | ||
| Net Income Common Stock | -90.05M | ||
| Net Income Common Stock (USD) | -90.05M | ||
| Consolidated Income | -90.05M | ||
| Earnings per Basic Share | -1.72 | ||
| Earnings per Basic Share (USD) | -1.72 | ||
| Earnings per Diluted Share | -1.72 | ||
| Earning Before Interest & Taxes (EBIT) | -81.34M | ||
| Earning Before Interest & Taxes (USD) | -81.34M | ||
| Weighted Average Shares | 52.43M | ||
| Weighted Average Shares Diluted | 52.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.26M | ||
| Cash and Equivalents (USD) | 17.26M | ||
| Investments | 135.26M | ||
| Investments Current | 135.26M | ||
| Trade and Non-Trade Receivables | 10.46M | ||
| Current Assets | 186.52M | ||
| Property, Plant & Equipment Net | 147.42M | ||
| Total Assets | 341.89M | ||
| Debt Current | 22.09M | ||
| Total Debt | 248.40M | ||
| Current Liabilities | 71.11M | ||
| Debt Non-Current | 226.30M | ||
| Total Liabilities | 320.81M | ||
| Accumulated Retained Earnings (Deficit) | -1.22B | ||
| Accumulated Other Comprehensive Income | -870.00K | ||
| Shareholders Equity | 21.08M | ||
| Shareholders Equity (USD) | 21.08M | ||
| Assets Non-Current | 155.38M | ||
| Total Debt (USD) | 248.40M | ||
| Deferred Revenue | 28.70M | ||
| Liabilities Non-Current | 249.70M | ||
| Trade and Non-Trade Payables | 21.21M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.86M | ||
| Net Cash Flow from Financing | -13.64M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.24M | ||
| Capital Expenditure | -1.24M | ||
| Issuance (Purchase) of Equity Shares | 794.00K | ||
| Issuance (Repayment) of Debt Securities | -13.37M | ||
| Net Cash Flow from Investing | 70.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 71.82M | ||
| Net Cash Flow from Operations | -76.19M | ||
| Share Based Compensation | 8.62M | ||